NCT04767178View on ClinicalTrials.gov

Pain Management During Screening for Retinopathy of Prematurity

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

July 30, 2020

Study Completion Date

August 15, 2020

Conditions
Retinopathy of PrematurityPain Management
Interventions
DRUG

Ibuprofen (Sanofi, Istanbul, Turkey)

Each enrolled infant received oral ibuprofen at a dose of 10 mg/kg 60 min before the onset of the eye examination.

DRUG

Paracetamol (GlaxoSmithKline, Istanbul, Turkey)

Each enrolled infant received oral paracetamol at a dose of 10 mg/kg 60 min before the onset of the eye examination.

Trial Locations (1)

34674

Medeniyet University, Istanbul

All Listed Sponsors
lead

Istanbul Medeniyet University

OTHER

NCT04767178 - Pain Management During Screening for Retinopathy of Prematurity | Biotech Hunter | Biotech Hunter